Talis Biomedical Co. (NASDAQ:TLIS – Get Free Report)’s stock price traded down 10.6% during mid-day trading on Thursday . The company traded as low as $1.04 and last traded at $1.56. Approximately 821 ...

Lifecore Biomedical, Inc. (($LFCR)) has held its Q3 earnings call. Read on for the main highlights of the call. Lifecore Biomedical, Inc.’s recent ...

This is a unique opportunity to experience the COPA™ system firsthand and engage directly with Berkshire’s leadership team in ...

Lifecore Biomedical (NASDAQ:LFCR – Get Free Report) is anticipated to release its earnings data on Thursday, April 3rd.

CHASKA, Minn., April 03, 2025 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (“Lifecore”), a fully integrated contract development and manufacturing organization (“CDMO”), today ...

Greenhaven Road Capital, an investment management company, released its fourth-quarter 2024 investor letter. A copy of the ...

A link to the live and archived webcast may be accessed on the Clearside website under the Investors section: Events and Presentations. An archive of the webcast will be available for three months.

The future of biomedical research in New York depends on our willingness to invest in state-supported programs today.

Despite a challenging quarter, Lifecore Biomedical Inc (LFCR) focuses on new agreements and operational improvements to drive future growth.

STOCKHOLM–Scientific and analytical instruments provider Advanced Instruments agreed to buy Nova Biomedical in a deal that values the company at $2.2 billion, including debt. Advanced Instruments is ...

NEW YORK — Tasso has struck a deal to offer its blood-collection devices in Japan through a new joint venture with Tokyo-based drug development services provider Shin Nippon Biomedical Laboratories, ...